COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

Начало・Списък с акции・Compass Pathways Plc ADR

Compass Pathways Plc ADR

Затворен

10.32 -2.18

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

10.01

Максимум

10.67

Ключови измерители
By Trading Economics
Приходи	44M -94M
Служители	156
EBITDA	91M -46M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+108.3% upside

Дивиденти
By Dow Jones
Следващи печалби	30.07.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	696M 1.3B
Предишно отваряне	12.5
Предишно затваряне	10.32

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

3.645 / 4.0539 Подкрепа & съпротива

Compass Pathways Plc ADR Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.05.2026 г., 22:47 ч. UTC

Горещи акции

Stocks to Watch: Macy's, Delta, UnitedHealth, NextNRG

15.05.2026 г., 22:16 ч. UTC

Придобивния, сливания и поглъщания

Canadian Tribunal Gives Keyera, Plains Until Late June to Rebut Bid to Undo Merger

15.05.2026 г., 22:00 ч. UTC

Значими двигатели на пазара

Delta Air Shares Rise as Berkshire Hathaway Discloses Stake

15.05.2026 г., 18:09 ч. UTC

Значими двигатели на пазара

Palo Alto Shares Head for Record-High Close, Analysts See Benefits to Identity Security Pivot

15.05.2026 г., 16:02 ч. UTC

Печалби

Значими двигатели на пазара

Forward Industries Shares Fall on New Debt as Solana Value Drops

15.05.2026 г., 14:55 ч. UTC

Значими двигатели на пазара

Aardvark Therapeutics Shares Plunge After FDA Hold on ARD-101 New Drug Application

15.05.2026 г., 14:43 ч. UTC

Значими двигатели на пазара

Chip Stocks Slide After U.S.-China Summit Ends Without Major Tech Deals -- Update

15.05.2026 г., 22:17 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Boosted Stake in Alphabet in First Quarter, Bought Delta Air, Sold Visa, Mastercard -- Barrons.com

15.05.2026 г., 21:59 ч. UTC

Придобивния, сливания и поглъщания

Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying. -- Barrons.com

15.05.2026 г., 21:50 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Boosted Stake in Alphabet in First Quarter, Bought Delta Air, Sold Visa, Mastercard -- Barrons.com

15.05.2026 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman's Pershing Square Bets on Microsoft's AI Ambitions With New Stake -- 4th Update

15.05.2026 г., 21:16 ч. UTC

Пазарно говорене

Canada Oil Producers Expect Govt Cash Before Building Pathways Project -- Market Talk

15.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

15.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

15.05.2026 г., 20:19 ч. UTC

Горещи акции

Stocks to Watch Recap: Intel, Nvidia, Amgen, LVMH -- WSJ

15.05.2026 г., 19:41 ч. UTC

Придобивния, сливания и поглъщания

SanDisk Stock Is Up 494% This Year. Insiders Are Cashing In on the AI-Fueled Surge. -- Barrons.com

15.05.2026 г., 19:35 ч. UTC

Пазарно говорене

Oil Futures Settle Higher on Inventory Worries -- Market Talk

15.05.2026 г., 19:33 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Rise as Weather Heats Up -- Market Talk

15.05.2026 г., 18:35 ч. UTC

Печалби

Xanadu Quantum Revenue Increases Fourfold. Why the Stock Is Falling. -- Barrons.com

15.05.2026 г., 17:28 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises by 5 to 415 -- Market Talk

15.05.2026 г., 16:50 ч. UTC

Придобивния, сливания и поглъщания

Microsoft Stock Moves Higher After Ackman Announces New Stake -- WSJ

15.05.2026 г., 16:24 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman's Pershing Square Bets on Microsoft's AI Ambitions With New Stake -- 3rd Update

15.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

15.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

15.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

15.05.2026 г., 15:55 ч. UTC

Пазарно говорене

Canada's 1Q Rebound Not a Turning Point -- Market Talk

15.05.2026 г., 15:20 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

15.05.2026 г., 15:20 ч. UTC

Пазарно говорене

Silver Plunges on Inflation Worries -- Market Talk

15.05.2026 г., 15:20 ч. UTC

Печалби

A Micron and Sandisk Peer Is Coming to U.S. Markets. What to Know About Japan's Kioxia. -- Barrons.com

15.05.2026 г., 14:33 ч. UTC

Пазарно говорене

Dollar Could Drift Higher as it Retains High-Yielding Status -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Compass Pathways Plc ADR Прогноза

Ценова цел

By TipRanks

108.3% нагоре

12-месечна прогноза

Среден 22.83 USD 108.3%

Висок 70 USD

Нисък 12 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за Compass Pathways Plc ADR през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

12 ratings

Купи

Задържане

Продай

Според 12 анализатори, дали борсови рейтинги на Compass Pathways Plc ADR през последните 3 месеца.

Техническа оценка

By Trading Central

3.645 / 4.0539Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bullish.

There are no events.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Compass Pathways Plc ADR

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.